Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pacific Biosciences of California Inc (PACB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9987
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consumables. Its products enable the identification of novel genes; characterization of alternatively spliced isoforms in prominent gene families, and targeted sequencing, and provide real-time kinetic data for characterization of epigenomes. Pacific Biosciences’ products are based on its novel single molecule, real-time (SMRT) sequencing technology. It caters to scientific and research communities, government and commercial entities. The company has subsidiaries in the US, Canada, Germany, Japan, China, Singapore, and the UK. Pacific Biosciences is headquartered in Menlo Park, California, the US.

Pacific Biosciences of California Inc (PACB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10
Equity Offering 11
Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11
Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13
Acquisition 15
Illumina to Acquire Pacific Biosciences of California 15
Pacific Biosciences May Sell Itself 17
Pacific Biosciences of California Inc – Key Competitors 18
Pacific Biosciences of California Inc – Key Employees 19
Pacific Biosciences of California Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 02, 2018: Pacific Biosciences of California reports second quarter 2018 financial results 21
Feb 01, 2018: Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results 22
Corporate Communications 23
Jul 31, 2018: Pacific Biosciences Appoints Christian Henry to Board of Directors 23
Legal and Regulatory 24
May 09, 2018: Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences 24
Feb 08, 2018: Oxford Nanopore Successfully Defends PacBio lawsuit 25
Government and Public Interest 26
Jul 30, 2018: Diversity of Unexpected CRISPR Edits Revealed by SMRT Sequencing 26
Other Significant Developments 27
Jun 06, 2018: Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria 27
May 21, 2018: Phase Genomics and Pacific Biosciences Announce the Release of Co-Developed Genome Assembly Phasing Software – ‘FALCON-Phase’ 28
Mar 15, 2018: Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gene Therapy Protocols 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pacific Biosciences of California Raises USD20.5 Million in Venture Funding 10
Pacific Biosciences of California Raises USD69 Million in Public Offering of Shares 11
Pacific Biosciences Raises USD150 Million in Public Offering Of Common Stock 13
Illumina to Acquire Pacific Biosciences of California 15
Pacific Biosciences May Sell Itself 17
Pacific Biosciences of California Inc, Key Competitors 18
Pacific Biosciences of California Inc, Key Employees 19
Pacific Biosciences of California Inc, Subsidiaries 20

List of Figures
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pacific Biosciences of California Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacific Biosciences of California Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務情報
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • M3 Midstream LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary M3 Midstream LLC (Momentum) is an independent oil and gas company that offers midstream oilfield services. The company provides services such as gas processing and treating, wellhead gathering, dehydration, fractionation, compression, and storage services for natural gas and natural gas liqu …
  • AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, infl …
  • Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Luitpold Pharmaceuticals Inc (Luitpold), a subsidiary of Daiichi Sankyo Company Ltd is a manufacturer and marketer of drugs and medical devices. The company provides injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, antidotes, critical care drugs, …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Z-Medica LLC:医療機器:M&Aディール及び事業提携情報
    Summary Z-Medica LLC (Z- Medica) is a medical device company that develops and manufactures hemostatic medical devices. The company’s products include sterile nonwoven gauzes, haemostatic sponges impregnated with kaolin, haemostatic bandages and hydrophilic roll dressings. Its QuikClot hemostatic de …
  • Kallpa Generacion SA:発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Bioasis Technologies Inc (BTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Hon Hai Precision Industry Co Ltd (2317):企業の財務・戦略的SWOT分析
    Hon Hai Precision Industry Co Ltd (2317) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • RTL Group S.A. (00007453):企業の財務・戦略的SWOT分析
    RTL Group S.A. (00007453) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ClearOne Inc (CLRO):企業の財務・戦略的SWOT分析
    Summary ClearOne Inc (ClearOne) formerly ClearOne Communications Inc, is a technology company that provides conferencing, collaboration, streaming, and digital signage solutions. The company provides professional conferencing, audio and video distribution, premium conferencing, tabletop conferencing …
  • LifeLock Inc:企業のM&A・事業提携・投資動向
    LifeLock Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LifeLock Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Clevexel Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Clevexel Pharma SAS (Clevexel) is a drug development company that develops drugs to treat diseases of the central nervous system. The company’s pipeline product portfolio includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease patien …
  • The Stars Group Inc (TSGI):企業の財務・戦略的SWOT分析
    The Stars Group Inc (TSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Adecco Group AG :企業の戦略・SWOT・財務情報
    Adecco Group AG - Strategy, SWOT and Corporate Finance Report Summary Adecco Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pilot Energy Ltd (PGY):企業の財務・戦略的SWOT分析
    Summary Pilot Energy Ltd (Pilot), formerly known as Rampart Energy Ltd, is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-481-P, and Australia EP …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆